Skip to search formSkip to main contentSkip to account menu

Dibekacin

Known as: 3',4' Dideoxykanamycin B, B, 3',4'-Dideoxykanamycin, D-Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1-6)-O-(2,6-diamino-2,3,4,6-tetradeoxy-alpha-D-erythro-hexopyranosyl-(1-4))-2-deoxy- 
An aminoglycoside antibiotic derived from kanamycin B. Dibekacin is active against bacterial strains that are resistant to kanamycin.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2016
Highly Cited
2016
Background Recent research suggests that heat exposure may increase the risk of traumatic injuries. Published heat-related… 
Review
2011
Review
2011
Iron overload is the most important cause of mortality in patients with thalassaemia major. Iron chelation is therefore a… 
Highly Cited
2004
Highly Cited
2004
Vestibular information is known to be important for accurate spatial orientation and navigation. Hippocampal place cells, which… 
Highly Cited
1982
Highly Cited
1982
The cochleo- and vestibulotoxicities of a new aminoglyco-sidic antibiotic, dibekacin, have been compared, in the guinea pig, with… 
Highly Cited
1976
Highly Cited
1976
A total of 319 clinical isolates known to be resistant to one or more aminoglycoside antibiotics were tested for their… 
1976
1976
The effect of antibiotics on phagocytosis and killing of Pseudomonas aeruginosa by rabbit polymorphonuclear leukocytes was… 
1975
1975
A clinical isolate Pseudomonas aeruginosa GN315 resistant to amikacin (AK), a new semisynthetic antibiotic, inactivated AK by…